Search results
A Combined Flu and COVID-19 Shot May Be Coming
Time via AOL· 3 days agoJacqueline Miller, senior vice president and head of development in infectious diseases at Moderna. There's a public-health advantage, too, she says,...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via AOL· 5 hours agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post via Yahoo News· 7 days agoROCK HILL, S.C. - Kashyap Patel looked forward to his team’s Friday lunches. All the doctors from...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 1 day agoThis development comes less than two weeks after Moderna received FDA approval for the first mRNA...
Past COVID-19 infection may protect people against some common colds
Euronews via Yahoo News· 20 hours agoResearchers said the study may help in the development of future vaccines against COVID-19 that also...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 4 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...
How A New Covid-19 Antibody Could Contribute To Advanced Vaccine Development
Forbes· 7 days agoIn the ongoing Omicron era, a new Covid-19 antibody could renew optimism for urgently required SARS-...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 14 hours agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
Q&A: Researcher discusses what we need to worry about with avian flu, and what we don't
Medical Xpress· 7 hours agoTo find out, we spoke to Stylianos Bournazos, a research associate professor in the Leonard Wagner Laboratory of Molecular Genetics and Immunology at Rockefeller, headed by Jeffrey V. Ravetch ...